DelMar Pharmaceuticals Invited to Present New Data on VAL-083 in the Treatment of Glioblastoma Multiforme at the Society for NeuroOncology Annual Meeting

Nov 6, 2014

VAL-083 Demonstrates Promise as a Potential Treatment for Non-small Cell Lung Cancer

Oct 9, 2014

DelMar Pharmaceuticals Announces Presentations at Upcoming Scientific Meetings

Oct 6, 2014

DelMar Pharmaceuticals to Present at the SeeThruEquity Fall Microcap Investor Conference

Sep 4, 2014

DelMar Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent for VAL-083

Sep 3, 2014

DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments

Aug 29, 2014

DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference

Aug 27, 2014

DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer

Aug 19, 2014

DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial

Jul 24, 2014

DelMar Pharmaceuticals Receives Funding from the Canadian Federal Government

Jul 9, 2014